Skip to main content
OpenTrials

Clinical trial condition

Rifampicin Resistant Tuberculosis

Explore clinical trials studying Rifampicin Resistant Tuberculosis. Study availability and eligibility vary by location and protocol.

6 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Rifampicin Resistant Tuberculosis trial results

Recruiting

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

NCT05081401

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations
  • Guiyang Public Health Treatment Center Guiyang, Guizhou, China
  • People's Hospital of Qiandongnan Kaili, Guizhou, China
  • The Third People's Hospital of Liupanshui Liupanshui, Guizhou, China
  • Affiliated Hospital of Zunyi Medical University Zunyi, Guizhou, China
View Trial Details
Not Yet Recruiting

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

NCT07268664

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations
  • The Third People's Hospital in Aksou Aksu, Xinjiang, China
  • Hetian Prefecture Infectious Diseases Hospital Hetian, Xinjiang, China
  • Center of Disease Prevention and Control in Kashi Area Kashgar, Xinjiang, China
View Trial Details
Completed

Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis

NCT05586230

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • Site 5071, Instituto de Puericultura e Pediatria Martagao Gesteira CRS Rio de Janeiro, Brazil
  • Site 31441, BJMC CRS Pune, India
  • Site 31976, PHRU Matlosana CRS Klerksdorp, North West, South Africa
  • Site 31790, Desmond Tutu TB Centre (DTTC) CRS Cape Town, South Africa
View Trial Details
Completed

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

NCT04062201

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations
  • Jose Pearson TB Hospital Port Elizabeth, Eastern Cape, South Africa
  • King DinuZulu Hospital Complex Durban, KwaZulu-Natal, South Africa
View Trial Details

Related conditions